ACOEM Member Price: Complimentary
Non-Member Price: $75.00
Presenter:
Natalie P. Hartenbaum, MD, MPH, FACOEM
President and Chief Medical Officer
OccuMedix
A lot is new since ACOEM published a “joint” guidance statement on Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers with AAOHN in 2015. As the laws surrounding the use of marijuana and other cannabinoids continues to change, the ability of the occupation health professional to handle related issues continues to become murkier, whether as a corporate medical director/advisor, a worker’s compensation provider, an examiner, a Medical Review Officer, or any other health care role providing services to employers. In the past, the “we mirror federal law to the extent possible” was an easy solution, but now with conflicting state and federal laws, it is important that occupational health professional understand how employers may address cannabinoids and where the issues may be going.
This webinar will review evolving marijuana laws as they relate to the workplace. Current federal law and the impact of the 2018 Agriculture Improvement Act (Farm Bill) will be discussed as will examples of state laws and statutes which may limit what employers may do or may set new requirements for users of marijuana whether medical or recreational. Considerations including safety-sensitive positions and defining impairment will be reviewed. Participants will be provided with resources to attempt to stay current or explore the topic in more detail.
Marijuana and the Workplace: The Ongoing Saga (ACOEM)
Enduring Material: Valid May 10, 2020 – May 9, 2023
Activity Format
This activity includes the following:
1. Educational Content
2. Comprehensive Post-test
The medium or combination of media used for this activity will be audio and video. Participants will view the pre-recorded webinar while listening to the audio. A self-assessment post-test will then be taken online, which will be submitted to ACOEM. Participants who answer at least 4 out of 5 questions correctly will be eligible to claim up to 1.0 AMA PRA Category 1 Credit™. This activity is an ABPM-approved LLSA/MOC Activity.
Learning Objectives:
1. Describe the current federal law on marijuana and the impact of the 2018 Agriculture Improvement Act. (Farm Bill).
2. Identify several examples of state laws and statutes which may limit what employers may do or may set new requirements for users of marijuana (medical or recreational).
3. Recognize safety-sensitive positions and determine ways to define impairment.
Posting and Termination Dates
Original Posting Date: The posting date will be the date that the activity is live on the LMS.
Estimate Time to Complete This Activity
Up to 1.0 hour
ACCME Accreditation Statement
The American College of Occupational and Environmental Medicine (ACOEM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The American College of Occupational and Environmental Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Preventive Medicine Maintenance of Certification (LLSA) Credit
This activity has been approved for 1.0 ABPM LLSA credit.
Disclosure Policy
As an ACCME-accredited provider of medical education, ACOEM must ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if they or their spouse/domestic partner has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below. All faculty are reminded that in addition to their disclosures listed here, that they are to verbally announce their disclosures (or lack thereof) at the beginning of their presentation. All reported conflicts have been managed and resolved.
Faculty
* Nothing to Disclose:
Natalie P. Hartenbaum, MD, MPH, FACOEM*
Planning Committee
* Nothing to Disclose:
Natalie P. Hartenbaum, MD, MPH, FACOEM*
Commercial Support
It should be noted that no commercial support was received for this program.